Published in PLoS One on January 11, 2011
Yeast reveal a "druggable" Rsp5/Nedd4 network that ameliorates α-synuclein toxicity in neurons. Science (2013) 1.85
α-Synuclein disrupts stress signaling by inhibiting polo-like kinase Cdc5/Plk2. Proc Natl Acad Sci U S A (2012) 0.91
The yeast sphingolipid signaling landscape. Chem Phys Lipids (2013) 0.90
Plasma ceramide and glucosylceramide metabolism is altered in sporadic Parkinson's disease and associated with cognitive impairment: a pilot study. PLoS One (2013) 0.90
Phosphatidylethanolamine deficiency disrupts α-synuclein homeostasis in yeast and worm models of Parkinson disease. Proc Natl Acad Sci U S A (2014) 0.86
Oxidative stress in Alzheimer's and Parkinson's diseases: insights from the yeast Saccharomyces cerevisiae. Oxid Med Cell Longev (2012) 0.85
Systematic lipidomic analysis of yeast protein kinase and phosphatase mutants reveals novel insights into regulation of lipid homeostasis. Mol Biol Cell (2014) 0.84
A biological perspective of CSF lipids as surrogate markers for cognitive status in HIV. J Neuroimmune Pharmacol (2013) 0.82
Contribution of yeast models to neurodegeneration research. J Biomed Biotechnol (2012) 0.78
Triclabendazole protects yeast and mammalian cells from oxidative stress: identification of a potential neuroprotective compound. Biochem Biophys Res Commun (2011) 0.76
The small molecule triclabendazole decreases the intracellular level of cyclic AMP and increases resistance to stress in Saccharomyces cerevisiae. PLoS One (2013) 0.75
Mitochondrial lipids in neurodegeneration. Cell Tissue Res (2016) 0.75
Dopaminergic Neurons Respond to Iron-Induced Oxidative Stress by Modulating Lipid Acylation and Deacylation Cycles. PLoS One (2015) 0.75
Ethanolamine and Phosphatidylethanolamine: Partners in Health and Disease. Oxid Med Cell Longev (2017) 0.75
Transformation of intact yeast cells treated with alkali cations. J Bacteriol (1983) 100.26
Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science (1997) 28.30
alpha-Synuclein locus triplication causes Parkinson's disease. Science (2003) 20.20
Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet (1998) 12.92
Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet (2009) 10.34
The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol (2004) 9.62
Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science (2004) 8.71
Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu Rev Neurosci (2003) 8.44
Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science (2006) 7.72
Molecular pathways of neurodegeneration in Parkinson's disease. Science (2003) 7.55
alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol (2002) 6.64
Mapping pathways and phenotypes by systematic gene overexpression. Mol Cell (2006) 6.42
Molecular pathophysiology of Parkinson's disease. Annu Rev Neurosci (2005) 5.93
Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science (2000) 5.62
Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct. Science (2001) 4.48
The chronological life span of Saccharomyces cerevisiae. Aging Cell (2003) 3.98
Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc Natl Acad Sci U S A (1993) 3.73
Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance. Nat Med (2007) 3.54
A 5-bp deletion in ELOVL4 is associated with two related forms of autosomal dominant macular dystrophy. Nat Genet (2001) 3.52
ELO2 and ELO3, homologues of the Saccharomyces cerevisiae ELO1 gene, function in fatty acid elongation and are required for sphingolipid formation. J Biol Chem (1997) 3.38
Genome-wide association study of plasma polyunsaturated fatty acids in the InCHIANTI Study. PLoS Genet (2009) 3.38
Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease. Nat Med (2002) 3.31
A suite of Gateway cloning vectors for high-throughput genetic analysis in Saccharomyces cerevisiae. Yeast (2007) 3.30
Bridging high-throughput genetic and transcriptional data reveals cellular responses to alpha-synuclein toxicity. Nat Genet (2009) 3.06
Yeast genes that enhance the toxicity of a mutant huntingtin fragment or alpha-synuclein. Science (2003) 2.89
Replicative aging in yeast: the means to the end. Annu Rev Cell Dev Biol (2008) 2.49
Serine palmitoyltransferase is the primary target of a sphingosine-like immunosuppressant, ISP-1/myriocin. Biochem Biophys Res Commun (1995) 2.42
Vesicle permeabilization by protofibrillar alpha-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism. Biochemistry (2002) 2.29
Alpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity. Hum Mol Genet (2006) 2.03
Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity. Hum Mol Genet (2005) 1.92
alpha-Synuclein and neuronal cell death. Mol Neurodegener (2009) 1.85
Proteasomal inhibition by alpha-synuclein filaments and oligomers. J Biol Chem (2004) 1.84
Sphingolipid functions in Saccharomyces cerevisiae. Biochim Biophys Acta (2002) 1.79
Functions and metabolism of sphingolipids in Saccharomyces cerevisiae. Prog Lipid Res (2006) 1.79
The chronological life span of Saccharomyces cerevisiae. Methods Mol Biol (2007) 1.72
Isolation and characterization of a gene affecting fatty acid elongation in Saccharomyces cerevisiae. J Biol Chem (1996) 1.71
Cloning and characterization of LAG1, a longevity-assurance gene in yeast. J Biol Chem (1994) 1.67
Ceramide biosynthesis is required for the formation of the oligomeric H+-ATPase Pma1p in the yeast endoplasmic reticulum. J Biol Chem (2002) 1.67
Heat shock prevents alpha-synuclein-induced apoptosis in a yeast model of Parkinson's disease. J Mol Biol (2005) 1.51
Molecular mechanisms of alpha-synuclein neurodegeneration. Biochim Biophys Acta (2008) 1.51
Ubiquitin-proteasome system and Parkinson's diseases. Exp Neurol (2005) 1.47
Plasma membrane localization is required for RGS4 function in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1998) 1.46
Homologs of the yeast longevity gene LAG1 in Caenorhabditis elegans and human. Genome Res (1998) 1.42
Serum sphingomyelins and ceramides are early predictors of memory impairment. Neurobiol Aging (2008) 1.35
Synthesis of sphingolipids with very long chain fatty acids but not ergosterol is required for routing of newly synthesized plasma membrane ATPase to the cell surface of yeast. J Biol Chem (2005) 1.32
A specific structural requirement for ergosterol in long-chain fatty acid synthesis mutants important for maintaining raft domains in yeast. Mol Biol Cell (2002) 1.32
Regulation of lipid biosynthesis in Saccharomyces cerevisiae by fumonisin B1. J Biol Chem (1995) 1.31
Functional mitochondria are required for alpha-synuclein toxicity in aging yeast. J Biol Chem (2008) 1.28
Alpha-synuclein and Parkinson's disease. FASEB J (2004) 1.27
Two endoplasmic reticulum (ER) membrane proteins that facilitate ER-to-Golgi transport of glycosylphosphatidylinositol-anchored proteins. Mol Biol Cell (1999) 1.24
Novel lipogenic enzyme ELOVL7 is involved in prostate cancer growth through saturated long-chain fatty acid metabolism. Cancer Res (2009) 1.12
Alpha-synuclein targets the plasma membrane via the secretory pathway and induces toxicity in yeast. Genetics (2005) 1.09
Alpha-synuclein adopts an alpha-helical conformation in the presence of polyunsaturated fatty acids to hinder micelle formation. Biochemistry (2006) 1.04
Fumonisin B1-induced sphingolipid depletion inhibits vitamin uptake via the glycosylphosphatidylinositol-anchored folate receptor. J Biol Chem (1997) 1.02
YGR198w (YPP1) targets A30P alpha-synuclein to the vacuole for degradation. J Cell Biol (2007) 1.00
Mammalian fatty acid elongases. Methods Mol Biol (2009) 0.92
Causes of Parkinson's disease: genetics of DJ-1. Cell Tissue Res (2004) 0.89
Genetic susceptibility in Parkinson's disease. Biochim Biophys Acta (2008) 0.89
Regulation of telomere length by fatty acid elongase 3 in yeast. Involvement of inositol phosphate metabolism and Ku70/80 function. J Biol Chem (2008) 0.85
Yeast cells lacking the CIT1-encoded mitochondrial citrate synthase are hypersusceptible to heat- or aging-induced apoptosis. Mol Biol Cell (2007) 0.85
Antinutritional effects of fumonisin B1 and pathophysiological consequences. Toxicol Lett (2003) 0.77
Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity. Mol Brain (2008) 1.61
Heat shock prevents alpha-synuclein-induced apoptosis in a yeast model of Parkinson's disease. J Mol Biol (2005) 1.51
The unfolding story of the Escherichia coli Hsp70 DnaK: is DnaK a holdase or an unfoldase? Mol Microbiol (2002) 1.25
LRRK2 secretion in exosomes is regulated by 14-3-3. Hum Mol Genet (2013) 1.15
Kinetic analysis of interdomain coupling in a lidless variant of the molecular chaperone DnaK: DnaK's lid inhibits transition to the low affinity state. Biochemistry (2002) 1.12
Deletion of DnaK's lid strengthens binding to the nucleotide exchange factor, GrpE: a kinetic and thermodynamic analysis. Biochemistry (2003) 1.02
YGR198w (YPP1) targets A30P alpha-synuclein to the vacuole for degradation. J Cell Biol (2007) 1.00
Interactions within the ClpB/DnaK bi-chaperone system from Escherichia coli. Arch Biochem Biophys (2005) 0.98
Novel suppressors of alpha-synuclein toxicity identified using yeast. Hum Mol Genet (2008) 0.94
Functional analysis of VPS41-mediated neuroprotection in Caenorhabditis elegans and mammalian models of Parkinson's disease. J Neurosci (2012) 0.92
A neuroprotective role for angiogenin in models of Parkinson's disease. J Neurochem (2010) 0.92
α-Synuclein disrupts stress signaling by inhibiting polo-like kinase Cdc5/Plk2. Proc Natl Acad Sci U S A (2012) 0.91
Importance of the D and E helices of the molecular chaperone DnaK for ATP binding and substrate release. Biochemistry (2003) 0.89
14-3-3theta protects against neurotoxicity in a cellular Parkinson's disease model through inhibition of the apoptotic factor Bax. PLoS One (2011) 0.89
"Ant" and "grasshopper" life-history strategies in Saccharomyces cerevisiae. PLoS One (2008) 0.89
Detection of a concerted conformational change in the ATPase domain of DnaK triggered by peptide binding. FEBS Lett (2003) 0.88
Characterization of two partially unfolded intermediates of the molecular chaperone DnaK at low pH. Biochemistry (2002) 0.87
Target validation: the Parkinson disease perspective. Dis Model Mech (2010) 0.84
Alpha-synuclein functions in the nucleus to protect against hydroxyurea-induced replication stress in yeast. Hum Mol Genet (2011) 0.84
Hierarchical Bayesian Modelling for Saccharomyces cerevisiae population dynamics. Int J Food Microbiol (2010) 0.82
Phosphate and succinate use different mechanisms to inhibit sugar-induced cell death in yeast: insight into the Crabtree effect. J Biol Chem (2011) 0.82
α-Synuclein overexpression represses 14-3-3θ transcription. J Mol Neurosci (2013) 0.81
The insect antimicrobial peptide, L-pyrrhocoricin, binds to and stimulates the ATPase activity of both wild-type and lidless DnaK. FEBS Lett (2004) 0.80
Angiogenin in Parkinson disease models: role of Akt phosphorylation and evaluation of AAV-mediated angiogenin expression in MPTP treated mice. PLoS One (2013) 0.80
Extraction of natural vitamin E from wheat germ by supercritical carbon dioxide. J Agric Food Chem (2002) 0.79
A peroxisome biogenesis deficiency prevents the binding of alpha-synuclein to lipid droplets in lipid-loaded yeast. Biochem Biophys Res Commun (2013) 0.77
Isocitrate dehydrogenase 1 is downregulated during early skin tumorigenesis which can be inhibited by overexpression of manganese superoxide dismutase. Cancer Sci (2012) 0.77
Switches, catapults, and chaperones: steady-state kinetic analysis of Hsp70-substrate interactions. Biochemistry (2005) 0.76
Triclabendazole protects yeast and mammalian cells from oxidative stress: identification of a potential neuroprotective compound. Biochem Biophys Res Commun (2011) 0.76
The small molecule triclabendazole decreases the intracellular level of cyclic AMP and increases resistance to stress in Saccharomyces cerevisiae. PLoS One (2013) 0.75